Exelixis (EXEL) Income towards Parent Company (2010 - 2026)
Exelixis' Income towards Parent Company came in at $212.05 million for Q2 2027, up 14.7% from $184.85 million a year earlier and up 0.8% from the prior quarter.
Powered by 
Analysis
Exelixis (EXEL) Income towards Parent Company (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jul 3, 2026, Exelixis reported Income towards Parent Company of $860.62 million, up 42.9% year-over-year; for FY2026, it came in at $782.57 million, up 50.1% from FY2025.
- Income towards Parent Company carries a five-year compound annual growth rate of 27.6% (FY2021 to FY2026).
- Going back by year, Income towards Parent Company was $521.27 million in FY2025, $207.77 million in FY2023 (+14.0%) and $182.28 million in FY2022 (-21.1%).
- The five-year range for quarterly Income towards Parent Company is $37.32 million (Q1 2025) to $244.53 million (Q4 2026).
- Year-over-year, Income towards Parent Company has increased for four consecutive quarters, with growth averaging 82.5% over the last six quarters.
- Business Quant data shows EXEL's Income towards Parent Company at $210.47 million (Q1 2027), $244.53 million (Q4 2026) and $193.58 million (Q3 2026) in the three quarters before Q2 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Exelixis | 14.53 Bn | 10.87 Bn | 608.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 212.05 Mn |
| Apr 3, 2026 | 210.47 Mn |
| Jan 2, 2026 | 244.53 Mn |
| Oct 3, 2025 | 193.58 Mn |
| Jul 4, 2025 | 184.85 Mn |
| Apr 4, 2025 | 159.62 Mn |
| Jan 3, 2025 | 139.86 Mn |
| Sep 27, 2024 | 117.97 Mn |
| Jun 28, 2024 | 226.12 Mn |
| Mar 29, 2024 | 37.32 Mn |
| Dec 29, 2023 | 85.52 Mn |
| Sep 29, 2023 | 1.04 Mn |
| Jun 30, 2023 | 81.18 Mn |
| Mar 31, 2023 | 40.03 Mn |
| Dec 30, 2022 | -30.17 Mn |
| Sep 30, 2022 | 73.21 Mn |
| Jul 1, 2022 | 70.67 Mn |
| Apr 1, 2022 | 68.57 Mn |
| Dec 31, 2021 | 95.17 Mn |
| Oct 1, 2021 | 38.20 Mn |
API Access
Exelixis Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=EXEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();